Covid-19 roundup: FDA all but rejects changes to authorized vaccine plans; Israel approves Moderna's vaccine as countries race to get shots in arms
Just one day after OWS chief Moncef Slaoui said he had pushed the FDA to consider halving Moderna’s Covid-19 vaccine doses to counteract distribution lags, the agency poured cold water on the notion Monday night, as well as on other potential alternatives.
The idea of changing authorized vaccine doses or schedules for any Covid-19 vaccine is “premature” and not supported by available data, FDA chief Stephen Hahn and CBER director Peter Marks said in a joint statement. Hahn said regulators have been following the recent debates and news reports about trying to get more people vaccinated more quickly, but noted altering any authorized procedure amounts to a “significant risk” for public health.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.